Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PFE

Pfizer (PFE)

Pfizer Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:PFE
DateTimeSourceHeadlineSymbolCompany
14/06/202421:21IH Market NewsAdobe Soars 15% Pre-Market; Visa and Mastercard Encounter Hurdles in $30 Billion Agreement, and MoreNYSE:PFEPfizer Inc
14/06/202417:00Business WireELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple MyelomaNYSE:PFEPfizer Inc
13/06/202406:30Business WirePfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular DystrophyNYSE:PFEPfizer Inc
12/06/202404:43Edgar (US Regulatory)Form 11-K - Annual report of employee stock purchase, savings and similar plansNYSE:PFEPfizer Inc
12/06/202404:39Edgar (US Regulatory)Form 11-K - Annual report of employee stock purchase, savings and similar plansNYSE:PFEPfizer Inc
10/06/202421:29IH Market NewsApple Showcases AI at WWDC 2024, Nvidia Stock Split Starts Today, and More NewsNYSE:PFEPfizer Inc
06/06/202406:05GlobeNewswire Inc.Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608NYSE:PFEPfizer Inc
05/06/202407:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
05/06/202407:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
04/06/202408:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
04/06/202400:00Business WirePfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare ConferenceNYSE:PFEPfizer Inc
01/06/202422:00Business WirePfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)NYSE:PFEPfizer Inc
01/06/202422:00Business WireTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin LymphomaNYSE:PFEPfizer Inc
01/06/202402:15Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:PFEPfizer Inc
31/05/202422:00Business WirePfizer’s LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease ProgressionNYSE:PFEPfizer Inc
23/05/202421:40IH Market NewsOpenAI and News Corp Seal Partnership, DuPont de Nemours Announces Division, and More NewsNYSE:PFEPfizer Inc
23/05/202402:39Edgar (US Regulatory)Form 8-K - Current reportNYSE:PFEPfizer Inc
17/05/202401:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
17/05/202401:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/05/202421:27IH Market NewsChubb Stock Soars 9% with Berkshire Acquisition, AST SpaceMobile jumps 37% on AT&T deal, and More NewsNYSE:PFEPfizer Inc
16/05/202420:00GlobeNewswire Inc.Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)NYSE:PFEPfizer Inc
13/05/202422:00PR Newswire (US)Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual MeetingNYSE:PFEPfizer Inc
13/05/202421:16IH Market NewsArm Sets 2025 Target for AI Chip Development, Amazon and Microsoft Commit Billions to French Investments, and MoreNYSE:PFEPfizer Inc
09/05/202423:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:PFEPfizer Inc
09/05/202421:53IH Market NewsBain Capital in Talks to Acquire PowerSchool; Blackstone Emerges Victorious in Hipgnosis Bidding War, and More NewsNYSE:PFEPfizer Inc
09/05/202405:56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:PFEPfizer Inc
06/05/202420:45Business WirePfizer Announces New Chief Strategy and Innovation OfficerNYSE:PFEPfizer Inc
01/05/202423:12IH Market NewsCVS Health, Starbucks, Shares Weaker; Pinterest SoarsNYSE:PFEPfizer Inc
01/05/202420:45Business WirePfizer Reports First-Quarter 2024 ResultsNYSE:PFEPfizer Inc
30/04/202408:40Business WireFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
 Showing the most relevant articles for your search:NYSE:PFE